# PBSV (Pharma-bio Serv, Inc.) - SEC EDGAR Financial Statements

> Pharma-bio Serv, Inc. reported $9.48M in revenue and net income of $252K for the trailing twelve months ended July 31, 2026 (up 19.0% year over year), with a 32.3% gross margin and a -1.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/PBSV
- Markdown: https://convexityos.com/fundamentals/PBSV.md
- SEC CIK: 0001304161
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001304161&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $9.48M | +19.0% YoY |
| Operating Income | TTM | -$155K | -1.6% margin |
| Net Income | TTM | $252K | 2.7% net margin |
| Diluted EPS | TTM | $0.01 | Split-adjusted |
| Free Cash Flow | TTM | -$421K | -4.4% FCF margin |
| Cash & ST Investments | Jul 31, 2026 | $7.06M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $9.00M | $9.51M | $16.98M | $19.40M | $20.12M | $21.56M | $19.51M | $17.80M | $13.30M | $19.54M |
| Cost of Revenue | $6.09M | $6.99M | $11.91M | $14.52M | $14.76M | $14.90M | $13.33M | $12.11M | $9.46M | -- |
| **Gross Profit** | $2.91M | $2.52M | $5.07M | $4.88M | $5.36M | $6.67M | $6.18M | $5.69M | $3.84M | $5.78M |
| Selling, General & Admin | $3.55M | $3.80M | $3.95M | $3.71M | $9.21M | $4.44M | $4.48M | $4.60M | $4.66M | $5.87M |
| **Operating Income** | -$638K | -$1.29M | $1.12M | $1.17M | -$3.85M | $2.23M | $1.70M | -$1.26M | -$778K | -$92K |
| **EBITDA** | -$578K | -$1.26M | $1.17M | $1.23M | -$3.78M | $2.31M | $1.80M | -$1.19M | -$670K | $221K |
| Interest Income | $38K | $246K | $320K | $0 | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$94K | -$755K | $1.69M | $1.19M | -$1.88M | $2.29M | $2.22M | $1.52M | -$774K | -$204K |
| Income Tax Expense | $6.2K | $22K | $377K | $182K | $213K | $239K | $136K | $2.79M | $3.9K | $53K |
| **Net Income** | -$100K | -$778K | $1.31M | $1.01M | -$2.09M | $2.05M | $2.09M | $1.28M | -$1.41M | -$257K |
| Basic EPS | -- | -- | -- | -- | -- | $0.09 | $0.09 | -- | -$0.06 | -$0.01 |
| **Diluted EPS** | -$0.00 | -$0.03 | $0.06 | -- | -- | $0.09 | $0.09 | -- | -$0.06 | -$0.01 |
| Basic Shares Outstanding | 22.9M | 23.0M | 23.0M | 23.0M | 23.0M | 23.0M | 23.1M | 23.1M | 23.1M | 23.0M |
| Diluted Shares Outstanding | 23.0M | 23.0M | 23.0M | 23.0M | 23.2M | 23.0M | 23.1M | 23.1M | 23.1M | 23.2M |

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.34M | $2.70M | $2.29M | $2.15M | $1.96M | $2.42M | $2.47M | $2.33M |
| Cost of Revenue | $1.64M | $1.80M | $1.57M | $1.40M | $1.39M | $1.60M | $1.70M | $1.61M |
| **Gross Profit** | $692K | $902K | $722K | $749K | $574K | $819K | $768K | $727K |
| Selling, General & Admin | $764K | $757K | $817K | $882K | $888K | $917K | $860K | $881K |
| **Operating Income** | -$72K | $145K | -$95K | -$133K | -$314K | -$98K | -$92K | -$154K |
| **EBITDA** | -$58K | $158K | -$80K | -$117K | -$298K | -$79K | -$83K | -$148K |
| Interest Income | -- | -- | $83K | -- | -- | -- | $138K | -$35K |
| Income Before Tax | -$11K | $239K | $36K | $4.3K | -$209K | $101K | $9.7K | -$15K |
| Income Tax Expense | $3.1K | $6.4K | $3.6K | $4.4K | -$4.8K | $5.5K | $1.1K | -$31K |
| **Net Income** | -$14K | $233K | $33K | -$102 | -$204K | $95K | $8.5K | $16K |
| **Diluted EPS** | -$0.00 | $0.01 | $0.00 | -- | -$0.01 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 22.9M | 22.9M | 22.9M | -- | 22.9M | 22.9M | 23.0M | -- |
| Diluted Shares Outstanding | 22.9M | 22.9M | 22.9M | -- | 22.9M | 22.9M | 23.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $14.46M | $17.47M | $17.14M | $15.49M | $16.03M | $11.59M | $13.77M |
| Short-Term Investments | $7.48M | $5.98M | $4.53M | $0 | -- | -- | $0 | $44K | $27K | $20K |
| **Cash & Short-Term Investments** | -- | -- | -- | $14.46M | $17.47M | $17.14M | $15.49M | $16.07M | $11.62M | $13.79M |
| Accounts Receivable, Net | $2.36M | $2.51M | $3.94M | $4.98M | $4.61M | $9.73M | $8.78M | $5.19M | $6.32M | $6.85M |
| Other Current Assets | -- | -- | -- | -- | -- | $469K | $454K | $394K | $443K | $981K |
| **Total Current Assets** | $13.39M | $15.70M | $19.40M | $19.94M | $22.82M | $28.58M | $25.97M | $23.41M | $21.68M | $21.63M |
| Property, Plant & Equipment, Net | $116K | $169K | $33K | $74K | $106K | $218K | $291K | $298K | $251K | $2.33M |
| Other Non-Current Assets | $121K | $226K | $112K | $131K | $353K | $270K | $367K | $418K | $423K | $36K |
| **Total Non-Current Assets** | $266K | $593K | $501K | $707K | $1.10M | $1.33M | $658K | $1.97M | $674K | $2.37M |
| **Total Assets** | $13.65M | $16.29M | $19.90M | $20.65M | $23.92M | $29.92M | $26.63M | $25.38M | $22.35M | $24.00M |
| Accounts Payable | -- | -- | -- | $1.63M | $2.07M | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $1.74M | $1.89M | $2.15M | $2.11M | $2.67M | $3.79M | $3.67M | $2.57M | $1.54M | $2.16M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | $18K | $18K | $0 | -- |
| **Total Non-Current Liabilities** | $0 | $690K | $1.62M | $1.99M | $2.34M | $3.41M | $2.36M | $2.55M | $60K | $29K |
| **Total Liabilities** | $1.74M | $2.58M | $3.78M | $4.09M | $5.01M | $7.20M | $6.03M | $5.11M | $1.60M | $2.19M |
| **Total Debt (incl. Leases)** | $29K | $194K | $347K | $487K | $617K | $860K | $78K | -- | -- | -- |
| Common Stock | $2.4K | $2.4K | $2.4K | $2.3K | $2.3K | $2.3K | $2.3K | $2.3K | $2.3K | $2.3K |
| Retained Earnings | $10.53M | $12.35M | $14.85M | $15.27M | $17.71M | $21.52M | $19.47M | $19.11M | $19.56M | $20.98M |
| Accumulated Other Comp. Income | $278K | $262K | $210K | $238K | $144K | $161K | $144K | $108K | $138K | -$166K |
| **Total Stockholders' Equity** | $11.91M | $13.72M | $16.13M | $16.56M | $18.91M | $22.72M | $20.61M | $20.26M | $20.75M | $21.81M |
| Total Equity | $11.91M | $13.72M | $16.13M | $16.56M | $18.91M | $22.72M | $20.61M | $20.26M | $20.75M | $21.81M |

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Short-Term Investments | $7.06M | $6.68M | $4.80M | $7.48M | $6.77M | $8.31M | $5.13M | $5.98M |
| Accounts Receivable, Net | $2.42M | $2.72M | $2.65M | $2.36M | $2.02M | $2.68M | $2.68M | $2.51M |
| **Total Current Assets** | $11.24M | $11.29M | $13.32M | $13.39M | $13.16M | $13.42M | $15.53M | $15.70M |
| Property, Plant & Equipment, Net | $80K | $92K | $104K | $116K | $132K | $145K | $160K | $169K |
| Other Non-Current Assets | $121K | $121K | $121K | $121K | $226K | $226K | $226K | $226K |
| **Total Non-Current Assets** | $201K | $213K | $224K | $266K | $430K | $486K | $543K | $593K |
| **Total Assets** | $11.44M | $11.50M | $13.55M | $13.65M | $13.59M | $13.90M | $16.08M | $16.29M |
| **Total Current Liabilities** | $995K | $1.05M | $3.31M | $1.74M | $1.66M | $1.78M | $3.42M | $1.89M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $661K | $690K |
| **Total Liabilities** | $995K | $1.05M | $3.31M | $1.74M | $1.66M | $1.78M | $4.08M | $2.58M |
| **Total Debt (incl. Leases)** | -- | -- | -- | $29K | $71K | $113K | $154K | $194K |
| Common Stock | $2.4K | $2.4K | $2.4K | $2.4K | $2.4K | $2.4K | $2.4K | $2.4K |
| Retained Earnings | $9.07M | $9.08M | $8.85M | $10.53M | $10.53M | $10.74M | $10.64M | $12.35M |
| Accumulated Other Comp. Income | $251K | $255K | $280K | $278K | $286K | $283K | $244K | $262K |
| **Total Stockholders' Equity** | $10.44M | $10.45M | $10.24M | $11.91M | $11.93M | $12.12M | $12.00M | $13.72M |
| Total Equity | $10.44M | $10.45M | $10.24M | $11.91M | $11.93M | $12.12M | $12.00M | $13.72M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$100K | $778K | -$1.31M | $1.01M | -$2.09M | $2.05M | $2.09M | $1.28M | -$1.41M | -$257K |
| Depreciation & Amortization | $60K | $23K | $48K | $51K | $73K | $86K | $99K | $75K | $108K | $313K |
| Stock-Based Compensation | $35K | $48K | $45K | $72K | $56K | $43K | $34K | $52K | $64K | $89K |
| Change in Receivables | $204K | $1.46M | $1.09M | $463K | -$135K | $944K | -$3.59M | $1.16M | $140K | $647K |
| **Operating Cash Flow** | -$215K | -$567K | $1.89M | $592K | $805K | $1.51M | -$2.21M | $3.72M | -$923K | $710K |
| Capital Expenditure | -$6.6K | -$160K | -$7.3K | -$19K | -$11K | -$56K | -$57K | -$122K | -$57K | -$1.81M |
| **Free Cash Flow** | -$222K | -$726K | $1.88M | $573K | $794K | $1.46M | -$2.27M | $3.60M | -$980K | -$1.10M |
| Purchases of Investments | -- | -- | -$4.21M | $0 | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$1.47M | -$1.36M | -$4.22M | -$19K | $1.30M | -$29K | $1.84M | -$116K | -$9.2K | -$1.78M |
| Share Repurchases | -$31K | -$11K | -$34K | -$82K | -$26K | -$1.7K | -$88K | -$57K | -$15K | -$46K |
| Dividends Paid | -$1.72M | -$1.72M | -$1.72M | -$3.45M | -$1.73M | -$1.73M | $0 | -- | -- | -- |
| **Financing Cash Flow** | -$1.75M | -$1.73M | -$1.76M | -$3.53M | -$1.75M | $205K | -$156K | -$1.80M | -$71K | -$69K |
| **Net Change in Cash** | -$3.39M | -$3.68M | -$4.02M | -$3.01M | $330K | $1.65M | -$540K | $4.44M | -$2.18M | -$1.12M |

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14K | $233K | $33K | -$102 | -$204K | $95K | $8.5K | $1.57M |
| Depreciation & Amortization | $14K | $14K | $15K | $16K | $16K | $19K | $9.4K | $5.9K |
| Stock-Based Compensation | $8.6K | $8.6K | $8.6K | $4.4K | $10.0K | $10K | $11K | $3.1K |
| Change in Receivables | $296K | -$78K | -$277K | -$348K | $675K | $62K | -$186K | $89K |
| **Operating Cash Flow** | $61K | -$365K | -$390K | $280K | $237K | -$302K | -$429K | $78K |
| Capital Expenditure | -$1.4K | -$2.3K | -$2.4K | -$350 | -$2.0K | -$4.3K | $0 | -$157K |
| **Free Cash Flow** | $60K | -$368K | -$393K | $279K | $234K | -$306K | -$429K | -$79K |
| **Investing Cash Flow** | -$326K | -$1.89M | $2.77M | -$857K | $1.63M | -$3.23M | $988K | $172K |
| Share Repurchases | $0 | -$709 | -$1.7K | -$9.2K | -$5.0K | -$17K | $0 | $0 |
| Dividends Paid | $0 | -$1.72M | -- | -- | $0 | -$1.72M | -- | $0 |
| **Financing Cash Flow** | $0 | -$1.72M | -$1.7K | -$9.2K | -$5.0K | -$1.74M | $0 | $0 |
| **Net Change in Cash** | -$273K | -$3.97M | $2.38M | -$579K | $1.86M | -$5.21M | $540K | $247K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 32.3% | 26.5% | 29.8% | 25.2% | 26.6% | 30.9% | 31.7% | 32.0% | 28.9% | 29.6% |
| **Operating Margin** | -7.1% | -13.5% | 6.6% | 6.1% | -19.2% | 10.3% | 8.7% | -7.1% | -5.8% | -0.5% |
| **Net Profit Margin** | -1.1% | -8.2% | 7.7% | 5.2% | -10.4% | 9.5% | 10.7% | 7.2% | -10.6% | -1.3% |
| Return on Equity (ROE) | -0.8% | -5.7% | 8.1% | 6.1% | -11.0% | 9.0% | 10.1% | 6.3% | -6.8% | -1.2% |
| Return on Assets (ROA) | -0.7% | -4.8% | 6.6% | 4.9% | -8.7% | 6.9% | 7.8% | 5.0% | -6.3% | -1.1% |
| Current Ratio | 7.70x | 8.32x | 9.01x | 9.46x | 8.55x | 7.54x | 7.08x | 9.13x | 14.05x | 10.02x |
| Quick Ratio | -- | -- | -- | 9.23x | 8.27x | 7.08x | 6.61x | 8.29x | 11.62x | 9.57x |
| Debt to Equity | 0.00x | 0.01x | 0.02x | 0.03x | 0.03x | 0.04x | 0.00x | -- | -- | -- |
| **Revenue Growth (YoY)** | -5.3% | -44.0% | -12.5% | -3.6% | -6.7% | +10.5% | +9.6% | +33.8% | -31.9% | -16.5% |
| Gross Profit Growth (YoY) | +15.7% | -50.3% | +3.8% | -8.9% | -19.6% | +7.9% | +8.6% | +48.0% | -33.6% | -22.7% |
| Operating Income Growth (YoY) | -- | -215.2% | -4.9% | -- | -273.2% | +31.2% | -- | -- | -- | -105.2% |
| **Net Income Growth (YoY)** | -- | -159.4% | +30.1% | -- | -201.9% | -1.7% | +63.1% | -- | -- | -115.8% |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -1.1% | -- | -- | -- | -115.7% |
| Operating Cash Flow Growth (YoY) | -- | -130.0% | +219.2% | -26.4% | -46.9% | -- | -159.4% | -- | -230.0% | +90.5% |
| Free Cash Flow Growth (YoY) | -- | -138.6% | +228.6% | -27.8% | -45.6% | -- | -163.0% | -- | -- | -3733.8% |
| 5Y Revenue / Share Growth | -58.2% | -51.1% | -4.2% | +46.5% | +2.9% | -7.5% | -29.4% | -48.2% | -59.1% | -11.6% |
| 10Y Revenue / Share Growth | -61.3% | -65.5% | -50.4% | -40.1% | -9.0% | +71.4% | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -104.9% | -137.4% | +2.9% | -- | -- | +26.6% | -13.8% | -74.9% | -127.1% | -107.3% |
| 10Y Net Income / Share Growth | -106.2% | -132.2% | -74.2% | -80.6% | -159.6% | +397.5% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 32.3% | 32.4% | 32.5% | 32.3% | 31.4% | 30.6% | 28.6% | 26.5% |
| **Operating Margin** | -1.6% | -4.4% | -7.3% | -7.1% | -7.2% | -7.5% | -9.8% | -13.5% |
| **Net Profit Margin** | 2.7% | 0.7% | -0.9% | -1.1% | -0.9% | -2.0% | -5.2% | -8.2% |
| Return on Equity (ROE) | 2.4% | 0.6% | -0.7% | -0.8% | -0.7% | -1.6% | -4.2% | -5.7% |
| Return on Assets (ROA) | 2.2% | 0.5% | -0.6% | -0.7% | -0.6% | -1.4% | -3.1% | -4.8% |
| Current Ratio | 11.30x | 10.80x | 4.03x | 7.70x | 7.93x | 7.54x | 4.54x | 8.32x |
| Debt to Equity | -- | -- | -- | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x |
| **Revenue Growth (YoY)** | +19.0% | +11.8% | -7.1% | -7.9% | -18.8% | +1.7% | +3.8% | -35.2% |
| Gross Profit Growth (YoY) | +20.5% | +10.2% | -6.0% | +3.1% | -9.6% | +32.4% | +43.4% | -21.9% |
| **Net Income Growth (YoY)** | -- | +144.3% | +285.0% | -100.6% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -74.3% | -- | -- | +256.6% | -- | -- | -159.2% | -74.6% |
| Free Cash Flow Growth (YoY) | -74.6% | -- | -- | -- | -- | -- | -159.2% | -125.4% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
